Papillary Tubal Hyperplasia
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 35 (11), 1605-1614
- https://doi.org/10.1097/pas.0b013e318229449f
Abstract
In contrast to the controversy regarding the terminology and behavior of ovarian noninvasive low-grade serous tumors [atypical proliferative serous tumor (APST) and serous borderline tumor], little attention has been directed to their origin. Similarly, until recently, proliferative lesions in the fallopian tube had not been extensively studied. The recent proposal that ovarian high-grade serous carcinomas are derived from intraepithelial carcinoma in the fallopian tube prompted us to evaluate the possible role of fallopian tube in the genesis of low-grade serous tumors. We have identified a lesion, designated “papillary tubal hyperplasia (PTH),” characterized by small rounded clusters of tubal epithelial cells and small papillae, with or without associated psammoma bodies, that are present within the tubal lumen and which are frequently associated with APSTs. Twenty-two cases in this study were selected from a population-based study in Denmark of approximately 1000 patients with low-grade ovarian serous tumors in whom implants were identified on the fallopian tube. Seven additional cases were seen recently in consultation at The Johns Hopkins Hospital (JHH). These 7 cases were not associated with an ovarian tumor. PTH was found in 20 (91%) of the 22 cases in the Danish study. On the basis of this association of PTH with APSTs with implants and the close morphologic resemblance of PTH, not only to primary ovarian APSTs but also to noninvasive epithelial implants and endosalpingiosis, we speculate that the small papillae and clusters of cells from the fallopian tube implant on ovarian and peritoneal surfaces to produce these lesions. The 7 JHH cases of PTH that were not associated with an ovarian tumor support the view that PTH is the likely precursor lesion. We propose a model for the development of ovarian and extraovarian low-grade serous proliferations (APST, noninvasive epithelial implants, and endosalpingiosis) that postulates that all of these lesions are derived from PTH, which appears to be induced by chronic inflammation. If this hypothesis is confirmed, it can be concluded that low-grade and high-grade ovarian tumors develop from tubal epithelium and involve the ovary secondarily.Keywords
This publication has 22 references indexed in Scilit:
- Fallopian Tube Correlates of Ovarian Serous Borderline TumorsThe American Journal of Surgical Pathology, 2011
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?The American Journal of Surgical Pathology, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryThe American Journal of Surgical Pathology, 2010
- Noninvasive and Invasive Micropapillary (Low-Grade) Serous Carcinoma of the OvaryThe American Journal of Surgical Pathology, 2003
- Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection?International Journal of Gynecological Pathology, 2002
- Mucosal Epithelial Proliferation of the Fallopian TubeInternational Journal of Gynecological Pathology, 1995
- Serous Borderline Tumors of the PeritoneumThe American Journal of Surgical Pathology, 1990
- Epithelial Hyperplasia of the Fallopian Tube. Its Association with Serous Borderline Tumors of the OvaryInternational Journal of Gynecological Pathology, 1989
- Lymphoid Tissue of the Normal Fallopian Tube—A Form of Mucosal-Associated Lymphoid Tissue (MALT)?International Journal of Gynecological Pathology, 1986
- Endosalpingiosis in the omentumThe American Journal of Surgical Pathology, 1982